NCT05771883 2023-05-24
A Clinical Study of Injectable IMM0306 in Combination With Lenalidomide
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
Phase 1/2 Unknown
Clinical Trials
6 trialsNCT01412307 2015-08-11
LEBEN
GiovanniPascale
Phase 1/2 Unknown
NCT01368757 2015-03-09
Lenalidomide in Patients With Chronic Myelomonocytic Leukemia
Arbeitsgemeinschaft medikamentoese Tumortherapie
Phase 1/2 Unknown
NCT01010243 2012-05-30
MM03
University of Regensburg
Phase 1/2 Unknown
NCT01002703 2011-08-12
Treatment With Lenalidomide, Bendamustine and Prednisone (RBP) in Patients With Relapsed or Refractory Multiple Myeloma
University of Leipzig
Phase 1/2 Unknown
NCT01166035 2010-07-20
TEXO
Medical University Innsbruck
Phase 1/2 Unknown